{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:02:24Z","timestamp":1790139744921,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032550","name":"Zydus Lifesciences","doi-asserted-by":"publisher","award":["690"],"award-info":[{"award-number":["690"]}],"id":[{"id":"10.13039\/100032550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178117","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T06:45:45Z","timestamp":1756881945000},"page":"178117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Usnoflast: A cutting-edge NLRP3 inhibitor attenuates colonic inflammation across diverse immunopathology"],"prefix":"10.1016","volume":"1006","author":[{"given":"Manoranjan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogeswar","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiren","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajinath","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayush","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Limje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramchandra","family":"Ranvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178117_bib1","article-title":"Angiogenesis in inflammatory bowel disease","volume":"2015","author":"Alkim","year":"2015","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178117_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2007.03441.x","article-title":"The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders","volume":"149","author":"Barksby","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000341681","article-title":"Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors","volume":"30","author":"Bauer","year":"2012","journal-title":"Dig. Dis."},{"key":"10.1016\/j.ejphar.2025.178117_bib4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"Bauer","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2025.178117_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4161\/gmic.19141","article-title":"Innate immune response to Salmonella typhimurium, a model enteric pathogen","volume":"3","author":"Broz","year":"2012","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2025.178117_bib6","first-page":"15","article-title":"Dextran sulfate sodium (DSS)\u2010induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.ejphar.2025.178117_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149129","article-title":"A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease","volume":"1842","author":"Chatterjee","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.178117_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.pathol.4.110807.092239","article-title":"NOD-like receptors: role in innate immunity and inflammatory disease","volume":"4","author":"Chen","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2025.178117_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.intimp.2010.11.025","article-title":"Regulation of adaptive immunity by the NLRP3 inflammasome","volume":"11","author":"Chen","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.178117_bib10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20111453","article-title":"IL-1\u03b2 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells","volume":"209","author":"Coccia","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178117_bib11","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2025.178117_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jep.2010.01.024","article-title":"Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model","volume":"128","author":"da Silva","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2025.178117_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clim.2018.12.005","article-title":"The loss of tolerance to CHI3L1\u2013a putative role in inflammatory bowel disease?","volume":"199","author":"Deutschmann","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib14","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0016-5085(94)90803-6","article-title":"Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice","volume":"107","author":"Dieleman","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178117_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2249.1998.00728.x","article-title":"Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines","volume":"114","author":"Dieleman","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.189.8.1169","article-title":"Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2\u2013type responses","volume":"189","author":"Dohi","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178117_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2010.02.012","article-title":"Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases","volume":"32","author":"Dupaul-Chicoine","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2025.178117_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physiolgenomics.00138.2010","article-title":"Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis","volume":"43","author":"Fang","year":"2011","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.ejphar.2025.178117_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.108.145862","article-title":"Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis","volume":"329","author":"Farooq","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178117_bib20","doi-asserted-by":"crossref","first-page":"G1055","DOI":"10.1152\/ajpgi.00328.2004","article-title":"Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis","volume":"288","author":"Fukata","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2025.178117_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/07853890701197615","article-title":"Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine","volume":"39","author":"Goyette","year":"2007","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2025.178117_bib22","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1002720","article-title":"Differential expression of NLRP3 among hematopoietic cells","volume":"186","author":"Guarda","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/cpdd.1318","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of ZY\u2010IL1 in three patients with cryopyrin\u2010associated periodic syndromes","volume":"13","author":"Hissaria","year":"2024","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ejphar.2025.178117_bib24","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.2147\/IJN.S413149","article-title":"Treatment of ulcerative colitis by cationic liposome delivered NLRP3 siRNA","author":"Huang","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2025.178117_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep39075","article-title":"NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis","volume":"6","author":"Itani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178117_bib26","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178117_bib27","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s10620-007-0075-z","article-title":"Increased expression of long pentraxin PTX3 in inflammatory bowel diseases","volume":"53","author":"Kato","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2025.178117_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178117_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1471","article-title":"A randomized, double\u2010blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis","volume":"13","author":"Klughammer","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.178117_bib30","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI200215256","article-title":"Collagen-binding integrin \u03b1 1 \u03b2 1 regulates intestinal inflammation in experimental colitis","volume":"110","author":"Krieglstein","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178117_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/ibd\/izac256","article-title":"Histones of neutrophil extracellular traps directly disrupt the permeability and integrity of the intestinal epithelial barrier","volume":"29","author":"Lai","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2025.178117_bib32","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.20060206","article-title":"Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis","volume":"203","author":"Lara-Tejero","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178117_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/cmi.2016.58","article-title":"Cellular and molecular regulation of innate inflammatory responses","volume":"13","author":"Liu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib34","article-title":"CXCL13 is elevated in inflammatory bowel disease in mice and humans and is implicated in disease pathogenesis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2249.2004.02599.x","article-title":"Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease","volume":"138","author":"Ludwiczek","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/gut.42.2.214","article-title":"Expression of interleukin 1\u03b2 and interleukin 1\u03b2 converting enzyme by intestinal macrophages in health and inflammatory bowel disease","volume":"42","author":"McAlindon","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2025.178117_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2005.12.007","article-title":"Chitinase 3\u2013like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells","volume":"130","author":"Mizoguchi","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178117_bib38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","article-title":"Antibodies to interleukin 12 abrogate established experimental colitis in mice","volume":"182","author":"Neurath","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178117_bib39","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s10620-021-07184-y","article-title":"NLRP3 inflammasome inhibitor OLT1177 suppresses onset of inflammation in mice with dextran sulfate sodium-induced colitis","volume":"67","author":"Oizumi","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2025.178117_bib40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","article-title":"A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice","volume":"98","author":"Okayasu","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178117_bib41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3389\/fphar.2018.01405","article-title":"A comparative study on the efficacy of NLRP3 inflammasome signaling inhibitors in a pre-clinical model of bowel inflammation","volume":"9","author":"Pellegrini","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178117_bib42","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/IAI.00417-06","article-title":"Caspase-1-mediated activation of interleukin-1\u03b2 (IL-1\u03b2) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar typhimurium infection","volume":"74","author":"Raupach","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejphar.2025.178117_bib43","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0016-5085(99)70070-3","article-title":"VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis","volume":"116","author":"Sans","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178117_bib44","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.3748\/wjg.v26.i39.5983","article-title":"Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses","volume":"26","author":"Shi","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.178117_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02686090","article-title":"Intestinal innate immunity and the pathogenesis of salmonella enteritis","volume":"37","author":"Srikanth","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejphar.2025.178117_bib46","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s10620-009-1112-x","article-title":"Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-\u03b1 expression","volume":"55","author":"Takagi","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2025.178117_bib47","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.3748\/wjg.v25.i33.4796","article-title":"Role of NLRP3 inflammasome in inflammatory bowel diseases","volume":"25","author":"Tourkochristou","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.178117_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/intimm\/dxv029","article-title":"The cell surface receptor Slamf6 modulates innate immune responses during Citrobacter rodentium-induced colitis","volume":"27","author":"van Driel","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejphar.2025.178117_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2023.01.004","article-title":"Inhibition of NLRP3 attenuates sodium dextran sulfate-induced inflammatory bowel disease through gut microbiota regulation","volume":"46","author":"Wang","year":"2023","journal-title":"Biomed. J."},{"key":"10.1016\/j.ejphar.2025.178117_bib50","article-title":"Formononetin administration ameliorates dextran sulfate sodium\u2010induced acute colitis by inhibiting NLRP3 inflammasome signaling pathway","volume":"2018","author":"Wu","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178117_bib51","doi-asserted-by":"crossref","first-page":"67300","DOI":"10.18632\/oncotarget.18619","article-title":"Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.178117_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2020.09.003","article-title":"Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development","volume":"147","author":"Zhou","year":"2021","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:33:48Z","timestamp":1780202028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925008714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"alternative-id":["S0014299925008714"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178117","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usnoflast: A cutting-edge NLRP3 inhibitor attenuates colonic inflammation across diverse immunopathology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178117"}}